These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16232126)

  • 1. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic methods for biomarker discovery in urine.
    Wilkey DW; Merchant ML
    Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary proteomics: a tool to discover biomarkers of kidney diseases.
    Dihazi H; Müller GA
    Expert Rev Proteomics; 2007 Feb; 4(1):39-50. PubMed ID: 17288514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary proteomics: towards biomarker discovery, diagnostics and prognostics.
    Thongboonkerd V
    Mol Biosyst; 2008 Aug; 4(8):810-5. PubMed ID: 18633482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of proteomics applied to the follow-up in stem cell transplantation.
    Weissinger EM; Mischak H; Ganser A; Hertenstein B
    Ann Hematol; 2006 Apr; 85(4):205-11. PubMed ID: 16463156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A streamlined approach to high-throughput proteomics.
    Stephens AN; Quach P; Harry EJ
    Expert Rev Proteomics; 2005 Apr; 2(2):173-85. PubMed ID: 15892563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].
    Opatrný K
    Vnitr Lek; 2004 Jul; 50(7):556-63. PubMed ID: 15323265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
    Fliser D; Wittke S; Mischak H
    Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Fang X; Balgley BM; Lee CS
    Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.
    Fagerquist CK; Bates AH; Heath S; King BC; Garbus BR; Harden LA; Miller WG
    J Proteome Res; 2006 Oct; 5(10):2527-38. PubMed ID: 17022624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of genomics and proteomics in nephrology.
    Stojnev S; Pejcic M; Dolicanin Z; Velickovic LJ; Dimov I; Stefanovic V
    Ren Fail; 2009; 31(8):765-72. PubMed ID: 19814648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies.
    Blonder J; Conrads TP; Veenstra TD
    Expert Rev Proteomics; 2004 Aug; 1(2):153-63. PubMed ID: 15966810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
    Qoronfleh MW
    Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
    Whiteley GR; Colantonio S; Sacconi A; Saul RG
    Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.